Cargando…
Absence of Longer Reorientation Times in Patients Undergoing Electroconvulsive Therapy and Concomitant Treatment with Lithium
OBJECTIVE: Lithium is a drug of choice in the treatment of bipolar disorder and refractory depressive disorders. However, previous research suggests lithium has a negative cognitive impact in recovery from electroconvulsive therapy (ECT) and a higher risk of delirium, so patients are often required...
Autores principales: | Martins-Ascencao, Ricardo, Rodrigues-Silva, Nuno, Trovão, Nuno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean College of Neuropsychopharmacology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553532/ https://www.ncbi.nlm.nih.gov/pubmed/34690124 http://dx.doi.org/10.9758/cpn.2021.19.4.695 |
Ejemplares similares
-
Lithium-Induced
Reorientation of Few-Layer MoS(2) Films
por: Sojková, Michaela, et al.
Publicado: (2023) -
PT694. Concomitant psychopharmacological treatments during electroconvulsive therapy
por: Chi, Su-Hyuk, et al.
Publicado: (2016) -
Safety of concomitant tranylcypromine treatment during electroconvulsive therapy (ECT) series
por: Kavakbasi, E., et al.
Publicado: (2022) -
Efficacy of Electroconvulsive Therapy in Bipolar Disorder with Mixed Features
por: Palma, Miguel, et al.
Publicado: (2016) -
Research reorientation
por: Chander, N. Gopi
Publicado: (2016)